Feature Channels: Dermatology

• share
• favorite_border

Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. As your body’s largest organ, it’s important to take good care of your skin. In recognition of National Healthy Skin Month in November, a board-certified dermatologist from the American Academy of Dermatology offers tips to help treat acne.

• share
• favorite_border

• share
• favorite_border

Hosted by Chulalongkorn University the APRU APEC University Leaders' Forum 2022 is the first post-pandemic in-person APEC meeting held to foster high-level dialogue between CEOs, policy leaders, university presidents, and top researchers. This event begins Nov 15 at 9 PM EST.

• share
• favorite_border

After sun exposure, people with systemic lupus erythematosus (SLE) frequently develop skin rashes, which often are accompanied by a flare of their overall disease. This connection between ultraviolet (UV) light and disease flares in lupus is well known, but the way in which UV exposure actually triggers the disease has been poorly understood.

• share
• favorite_border

Christopher Bengson MD, MHS, FAAD, a board-certified dermatologist for the Indian Health Service in Phoenix, Ariz., and a Commander in the U.S. Public Health Service, was named an American Academy of Dermatology Patient Care Hero for making a life-saving recommendation that prevented a heart attack in a psoriasis patient.

• share
• favorite_border

Here are some of the latest articles that have been added to the Arthritis channel on Newswise.

• share
• favorite_border

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether or not patients also had systemic lupus erythematosus (SLE or lupus).

• share
• favorite_border

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, showed that the Vision Transformer, an open-source computer vision algorithm, could detect changes in nailfold capillaroscopy images from systemic sclerosis patients.

• share
• favorite_border

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found no clear association between immunosuppressive or anti-fibrotic medications and worsening gastrointestinal symptoms in early systemic scleroderma.

• share
• favorite_border

Five key messages for general and specialist care providers, as well as caregivers, promote best practices for managing atopic dermatitis in infants.

• share
• favorite_border

Researchers at Cornell University have come up with a reliable, skin-tight computing system that’s easy to attach and detach, and can be used for a variety of purposes – from health monitoring to fashion.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts.

• share
• favorite_border

The American College of Rheumatology (ACR) has released Continuing Medical Education (CME) for dermatologists and nephrologists to help them learn more about clinical trials for lupus patients in their treatment areas and the importance of getting more of African American/Black patients enrolled.

• share
• favorite_border

Your skin is a window to your overall health, and what happens on your skin is often an indicator of what’s happening inside your body.

• share
• favorite_border

A new way of reprogramming our immune cells to shrink or kill off cancer cells has been shown to work in the otherwise hard to treat and devastating skin cancer, melanoma.

• share
• favorite_border

ROSEMONT, Ill. (October 27, 2022) — Eczema, or atopic dermatitis, is a common skin condition affecting 1 in 10 Americans. Patients with eczema often experience itchy, dry, raw, and sensitive patches of skin, which greatly impacts their quality of life. As we wrap up Eczema Awareness Month, board-certified dermatologists provide easy steps you can take at home to ease your symptoms.

• share
• favorite_border

Giving the combination of immune checkpoint inhibitors relatlimab and nivolumab to patients with stage III melanoma before surgery was safe and completely cleared all viable tumor in 57% of patients in a Phase II study, researchers from The University of Texas MD Anderson Cancer Center reported in Nature.

• share
• favorite_border

In recognition of National Healthy Skin Month in November, board-certified dermatologists are providing their top tips for caring for your skin, hair, and nails.

• share
• favorite_border

The latest articles that have been added to the Environmental Health channel.

• share
• favorite_border

The use of next-generation, single-port surgical robots leads to improved cosmetic outcomes and patient perceptions of scarring after robotic kidney, bladder, or prostate surgery, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA).

• share
• favorite_border

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. Current advances include a combination approach to overcome PARP inhibitor resistance in breast and ovarian cancers, a deeper understanding of STAT3 mutations as drivers of disease progression, insights into the “obesity paradox” in men with advanced melanoma, a prognostic model for rapidly progressing vestibular schwannoma, and a role for cellular trafficking proteins in creating a metastasis-promoting lung cancer microenvironment.

• share
• favorite_border

A total of 54 Mercy Medical Center physicians were recognized in Baltimore magazine’s November 2022 “Top Doctors” issue, representing 28 separate specialties.

• share
• favorite_border

Researchers at Binghamton University, State University of New York are working to understand the molecular composition of tattoo inks to provide knowledge to artists and consumers.

• share
• favorite_border

• share
• favorite_border

Thanks to the internet, we have the world at our fingertips, and with just a few clicks, we can easily enter our medical symptoms into websites and apps to self-diagnose illnesses. However, a new article published in the Journal of the American Academy of Dermatology reveals that online symptom checkers are often inaccurate in identifying skin rashes.

• share
• favorite_border

Researchers at Huntsman Cancer Institute have solved a long-standing mystery about how a cancer-promoting protein causes drug-resistent tumors to grow. They hope the discovery leads to more effective cancer drugs. Ben Myers, PhD, explains how this new science is closing the gap in understanding brain and skin tumors and how to combat them.

• share
• favorite_border

A new, creative and innovative, minimally invasive skin-stretching device provides a promising alternative for surgical treatment of large scalp defects, reports a paper in The Journal of Craniofacial Surgery. The journal, under the guidance of Editor-in-Chief Mutaz B. Habal, MD, FRCSC, is published in the Lippincott portfolio by Wolters Kluwer.

• share
• favorite_border

The drug tofacitinib was well tolerated among patients with early scleroderma, primarily affecting the protein interferon both in fibroblasts and keratinocytes. Researchers say the drug is safe and can possibly be repurposed for systemic sclerosis treatment.

• share
• favorite_border

• share
• favorite_border

ROSEMONT, Ill. (October 4, 2022) — There are many ways to get rid of unwanted facial and body hair, but shaving with a razor is one of the most common and inexpensive methods. Unfortunately, using a razor sometimes can lead to razor bumps, also called shaving bumps. Board-certified dermatologists share simple tips that can help treat this skin condition.

• share
• favorite_border

A clinical trial led by clinicians at Georgetown Lombardi Comprehensive Cancer Center showed a remarkable 20 percent advantage in the two-year overall survival rate for people with advanced melanoma who first received immunotherapy (72 percent survival rate) versus those who initially got targeted therapies (52 percent survival rate). Progression-free survival, where the cancer is stable or improving, was also trending in favor of those who started on immunotherapy.

• share
• favorite_border

Hand eczema is one of the most common forms of eczema, causing dry, itchy, and irritated skin affecting the whole hand, including the fingers. This skin condition can negatively impact a person’s quality of life because we use our hands often. In recognition of Eczema Awareness Month in October, board-certified dermatologists share information about the causes of hand eczema and how it can be treated to keep the condition from worsening.

• share
• favorite_border

Two recent UC Davis studies reveal how skin forms differently across different areas of the body from the face and underarms to the palms of our hands and feet. By profiling the changes in skin, researchers found that the differences have a direct impact for how various skin diseases form across the body.

• share
• favorite_border

Apremilast (brand name Otezla) has helped psoriasis patients achieve clearer skin and ease the symptoms of their psoriatic arthritis. Now, new data from researchers at the Perelman School of Medicine at the University of Pennsylvania shows it could also help people with psoriasis shed unhealthy body fat and therefore improve cardiovascular health, a well-known vulnerability for those with psoriasis.

• share
• favorite_border

Researchers from Tel Aviv University deciphered, for the first time, a mechanism that enables skin cancer to metastasize to the brain and managed to delay the spread of the disease by 60% to 80% using existing treatments.

• share
• favorite_border

Currently, the only FDA approved biomarker for ICI melanoma treatment is the tumor mutation burden assay, but the mechanisms linking it to ICI remain unclear. However, new research out of The Wistar Institute now provides evidence of novel, reliable biomarkers that predict therapy response using advanced computer technology.

• share
• favorite_border

The latest research and expert commentary on pain management.

• share
• favorite_border

A team of engineers and doctors at the University of Minnesota Twin Cities have designed a unique 3D-printed light-sensing medical device that could help millions of people worldwide with lupus and other light-sensitive diseases.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. This special edition features upcoming oral presentations by MD Anderson researchers at the European Society for Medical Oncology (ESMO) Congress 2022 focused on clinical advances across a variety of cancer types. Highlights include promising early data from a novel T cell therapy for solid tumors, targeted therapy progress in rare and advanced cancers, biomarkers of immunotherapy response, and features associated with clinical outcomes in leptomeningeal disease. More information on ESMO content from MD Anderson can be found at MDAnderson.org/ESMO.

• share
• favorite_border

• share
• favorite_border

In early experiments, Jianjun Guan and his team found that after applying a single dose of their wound dressing into wounds in young diabetic mice, the wounds completely closed at day 14. Wounds that were treated only with the hydrogel or were untreated were reduced to roughly half of their original size.

• share
• favorite_border

Researchers at Sanford Burnham Prebys, led by Ze’ev Ronai, Ph.D., have shown for the first time that inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth. Published in Nature Cell Biology, these findings could lead to a new class of drugs to selectively treat melanoma, the most severe form of skin cancer.

• share
• favorite_border

The latest research on plants brought to you by Newswise.